How to Buy Addus Homecare Stock
Addus Homecare Corp
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.
Addus Homecare stock last closed at $97.16, up 0.56% from the previous day, and has decreased 10.96% in one year. It has underperformed other stocks in the Medical Care Facilities industry by 0.14 percentage points. Addus Homecare stock is currently +25.69% from its 52-week low of $77.30, and -15.49% from its 52-week high of $114.97.
At the moment, there are 16.23M ADUS shares outstanding. The market capitalization of ADUS is $1.58B. In the last 24 hours, 116,377 ADUS shares were traded.
How to Buy Addus Homecare Stock
Wondering how to invest in Addus Homecare stock? Here's how.
- Decide where to buy Addus Homecare stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you choose where to buy Addus Homecare stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Choose your payment method and add your information.
- Analyze Addus Homecare stock: The Addus Homecare ticker symbol is ADUS. Is Addus Homecare stock a good investment? Should you buy shares of ADUS? How do ADUS's underlying business fundamentals look? Do top analysts think Addus Homecare is a good buy? Why has ADUS's stock price moved recently? (Hint: Our stock market analysis website can help you understand if ADUS is a good stock to buy).
- Make your ADUS purchase: Decide if you will purchase ADUS shares at the current market price or use a limit order to buy ADUS stock at a particular price.
- Get key alerts regarding your ADUS investment: Create a watchlist to important notifications about your new investment in Addus Homecare stock.
Step 1: Decide where to buy Addus Homecare stock
You need a brokerage account to access the NASDAQ market and buy ADUS stock.
Our recommended brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Real Estate, New York to Tokyo — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountStep 2: Create a brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal info so you are able to invest in ADUS stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create a new trading account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've filled out your info on mobile trading apps, your next step is to transfer the money for your investment:
Watch the tutorial below for more details transferring money into your new investment account.
Step 4: Analyze Addus Homecare stock
After you have figured out the best place to buy Addus Homecare stock, it's important to evaluate their stock prior to investing, so you truly comprehend the risk as well as the upside.
Addus Homecare stock data
Fundamentals of ADUS
WallStreetZen was created to help part-time investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ADUS's stock page.
Is ADUS stock properly valued?
Investors use many financial metrics, analyses, models, and charts to gauge ADUS's true value.
Using relative valuations metrics:
- ADUS may be undervalued based on its P/E ratio of 24.85x, relative to Medical Care Facilities industry P/E ratio of -3.03x
- ADUS may be undervalued based on its P/B ratio of 2.23x, relative to Medical Care Facilities industry P/B ratio of 4.36x
- ADUS may be overvalued based on its PEG ratio of 1.45x
You can do additional valuation research on ADUS's stock here.
A quick look at ADUS Financials
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the ADUS balance sheet.
- ADUS's operating cash flow of $112.25M allows it to safely service it's debt of $175.18M.
- ADUS earnings of $92.43M is not sufficient to cover its interest payments.
- ADUS profit margin has gone up from 4.8% to 5.9% in the past year.
- There are more short-term assets than long-term liabilities on the ADUS balance sheet.
Failed Financial Due Diligence Checks:
- Total ADUS debt is higher than 5 years ago, relative to shareholder equity.
- ADUS has a relatively high debt to equity ratio of 0.45.
Is it a good time to buy ADUS stock, according to analysts?
Out of 5 Wall Street analysts who give ratings on ADUS, the consensus analyst rating on ADUS is a Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Addus Homecare stock forecast page.
ADUS Technicals
ADUS Growth Metrics
Last year, ADUS earnings were $62.52M. In the last five year, ADUS's earnings have increased by 23.52% per year. This was faster than the Medical Care Facilities industry average of 11.7%.
Last year, ADUS revenue was $1.06B. Over the past 5 year, ADUS's revenue has increased by 15.43% per year. This was faster than the Medical Care Facilities industry average of 7.69%.
You can analyze ADUS's earnings and revenue performance here.
What are ADUS insiders up to?
In the last 12 months, executives and large shareholders at ADUS have sold more shares than they have bought.
Roberton James Stevenson, EVP Chief HR Officer of ADUS, was the latest ADUS insider to sell. They sold $11,328.37 worth of ADUS stock on Apr 1, 2024.
Research more about who owns ADUS stock here.
Can I rely on ADUS as an income stream?
No, Addus Homecare doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your ADUS purchase
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually sufficient. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount, place a limit order.
Hit the Open Trade button and eToro will place the order.
If you require more assistance buying stocks on eToro, click the helpful video below:
Step 6: Get key alerts regarding your ADUS investment
Now that you own some shares in ADUS, you'll want to stay up-to-date on your new shares.
Put ADUS on a watchlist to monitor your ADUS stock.
ADUS Feed
How to Buy Stock in Addus Homecare
To reiterate, here are the 6 steps to buy Addus Homecare stock:
- Decide where to buy Addus Homecare stock
- Create a brokerage account
- Deposit funds into your investment account
- Analyze Addus Homecare stock
- Make your ADUS purchase
- Get key alerts regarding your ADUS investment
If you need a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Addus Homecare, create your watchlist below.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.